Curanex Pharmaceuticals Inc (CURX) SEC Filings — 2025
11 SEC filings for Curanex Pharmaceuticals Inc (CURX) in 2025.
Filings
- Curanex's R&D Surge Drives Losses, IPO Boosts Cash to $5.8M — 10-Q · Nov 17, 2025
- Curanex Pharmaceuticals Faces Delisting Notice — 8-K · Nov 6, 2025
- Curanex Pharmaceuticals Reports Unregistered Equity Sales — 8-K · Sep 29, 2025
- Curanex Pharmaceuticals Files 8-K — 8-K · Sep 12, 2025
- Curanex Losses Mount, IPO Funds Ulcerative Colitis Drug Development — 10-Q · Sep 9, 2025
- Curanex Pharmaceuticals Files 8-K — 8-K · Aug 27, 2025
- Curanex Pharmaceuticals Enters Material Definitive Agreement — 8-K · Aug 26, 2025
- Curanex Pharmaceuticals Inc S-1/A Filing — S-1/A · Jul 18, 2025
- Curanex Pharma Amends S-1/A for Public Offering — S-1/A · Jul 1, 2025
- Curanex Pharma Files S-1/A for IPO — S-1/A · Mar 17, 2025
- Curanex Pharmaceuticals Files S-1/A for IPO — S-1/A · Feb 14, 2025